|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/09 | |||
| C07K 14/315 |
| (11) | Number of the document | 2908856 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13779191.9 |
| Date of filing the European patent application | 2013-10-15 | |
| (97) | Date of publication of the European application | 2015-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/071477 |
| Date | 2013-10-15 |
| (87) | Number | WO 2014/060385 |
| Date | 2014-04-24 |
| (30) | Number | Date | Country code |
| 201218660 | 2012-10-17 | GB | |
| 201261714942 P | 2012-10-17 | US | |
| 201261714956 P | 2012-10-17 | US | |
| 201313826696 | 2013-03-14 | US | |
| 201313826932 | 2013-03-14 | US | |
| 201313827203 | 2013-03-14 | US |
| (72) |
VERLANT, Vincent, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | IMMUNOGENIC COMPOSITION |
| IMMUNOGENIC COMPOSITION |